F2RL1 and bone neoplasm: Although our findings of PAR-2-mediated BDNF overexpression in epithelial cells has never been tested by others, they are supported by recent data in dorsal horn showing that PAR2-activation can upregulate BDNF, which contributes to central sensitization in rats with bone cancer pain21.